“Most fields of healthcare technology are growing with aging populations and treating illness. But, one place we’re not seeing growth, on a global scale, is with bringing new life into this world.”
Vancouver, BC (PRWEB) February 09, 2015
According to a new report published by iData Research, only the U.S. market for fetal and neonatal monitoring devices is showing signs of growth, while other developed countries around the globe face stagnation or declines. In the United States, prices continue to increase at steady increments as innovation and technology continues to evolve.
“The U.S. has always been a major global developer of new healthcare technologies, which explains the U.S. medical market growth through innovation,” explains Dr. Kamran Zamanian, CEO of iData. “Most fields of healthcare technology are growing with aging populations and treating illness. But, one place we’re not seeing growth, on a global scale, is with bringing new life into this world.”
As low birth rates are becoming a problem internationally, medical device market challenges may be seen as a warning to countries more concerned with investing in the health and well-being of the older generation over the younger.
The U.S. Market
As one of the few fetal and neonatal monitoring markets to show growth, the U.S. market is driven by innovation and new technologies. Hospitals more readily upgrade their facilities to integrate with central monitoring and information archiving, giving physicians better patient profiles at their fingertips.
The Europe Market
With near-zero market growth, the fetal and neonatal monitoring market in Europe is stable, but still price-sensitive. Hospitals in Europe continue to update their facilities much like in the U.S., but pricing competition drives manufacturer revenues down.
The Asia-Pacific Market
Market declines in Japan, Australia, and South Korea are much more prevalent. With fewer and fewer units moved year-over-year, coupled with declining prices, fetal and neonatal monitoring manufacturers with presence in these countries are faced with a unique challenge.
Leading Global Competitors
In the iData analysis of global fetal and neonatal monitoring markets, Philips Healthcare and GE Healthcare hold the top positions everywhere except Japan. Hospitals in Japan are dominated by a local competitor, due to a strong local sales force and long-standing relationships. Leading companies in fetal and neonatal monitors all offer a diverse array of integrated monitoring technology to stay competitive.
For Further Information
More on the global market for fetal and neonatal monitoring can be found in the 2014 edition report published by iData entitled Global Markets for Fetal and Neonatal Monitoring, which covers the U.S., South Korea, Japan, Australia, and 15 European countries.
Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
Register online or email us at info(at)idataresearch(dot)net for a Global Market for Fetal and Neonatal Monitoring report brochure and synopsis.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.